Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Interventional × Communication × Clear all

Phase

Status

Sponsor Class

OTHER 64 OTHER_GOV 1 NIH 1

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Breast Neoplasms 363 Lymphoma 268 Carcinoma, Non-Small-Cell Lung 236 Melanoma 233 Prostatic Neoplasms 219 Precursor Cell Lymphoblastic Leukemia-Lymphoma 218 Leukemia, Lymphocytic, Chronic, B-Cell 210 Leukemia, Myeloid, Acute 197 Lung Neoplasms 194 Colonic Neoplasms 191 Neoplasms 187 Lymphoma, Non-Hodgkin 187 Lymphoma, Large B-Cell, Diffuse 184 Leukemia 184 Rectal Neoplasms 174 Lymphoma, Follicular 174 Colorectal Neoplasms 172 Ovarian Neoplasms 163 Multiple Myeloma 162 Burkitt Lymphoma 159 Brain Neoplasms 155 Neoplasm Metastasis 152 Carcinoma, Renal Cell 148 Sarcoma 144 Lymphoma, Mantle-Cell 144 Glioblastoma 139 Pancreatic Neoplasms 133 Unspecified Adult Solid Tumor, Protocol Specific 129 Lymphoma, B-Cell, Marginal Zone 123 Carcinoma, Ovarian Epithelial 119

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00774254 2024-10-01

Reactions to Disease Risk Information

National Institutes of Health Clinical Center (CC)

Phase NA Completed

Communication, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡